procedure B, the title compound was prepared starting from 2e (50.5 mg, 0.248 mmol). Silica gel
1
chromatography afforded the analytically pure product (48.9 mg, 79% yield) as a white solid. H NMR
(CDCl3): δ = 2.35 (s, 6 H), 3.34 (s, 6 H), 6.85 (s, 2 H), 7.43 (d, J = 14.3 Hz, 2 H), 7.46 (t, J = 9.2 Hz, 1 H),
7.59 (d, J = 9.1 Hz, 2 H). 13C NMR (CDCl3): δ = 19.97, 29.72, 109.55, 109.62, 126.61, 127.88, 128.50,
134.02, 136.50. HRMS (EI): m/z calcd for C16H19BN2 [M+]: 250.1641; found: 250.1642.
Ethyl 4-(1,3,5,6-Tetramethyl-1,3-dihydro-2H-benzo[d][1,3,2]diazaborol-2-yl)benzoate (3b). Following
the general procedure B, the title compound was prepared starting from 2b (68.3 mg, 0.247 mmol). Silica
gel chromatography afforded the analytically pure product (55.0 mg, 69% yield) as a white solid. 1H NMR
(CDCl3): δ = 1.42 (t, J = 7.0 Hz, 3H), 2.36 (s, 6H), 3.34 (s, 6H), 4.42 (q, J = 7.1 Hz, 2H), 6.87 (s, 2H), 7.67
(d, J = 8.1 Hz, 2H), 8.12 (d, J = 8.3 Hz, 2H). 13C NMR (CDCl3): δ = 14.35, 19.98, 29.71, 60.95, 109.71,
123.95, 128.72, 130.30, 133.91, 136.36, 166.81. HRMS (EI): m/z calcd for C19H23BN2O2 [M+]: 322.1853;
found: 322.1848.
1-(4-(1,3,5,6-Tetramethyl-1,3-dihydro-2H-benzo[d][1,3,2]diazaborol-2-yl)phenyl)ethan-1-one
(3f).
Following the general procedure B, the title compound was prepared starting from 2f (65.8 mg, 0.267
mmol). Silica gel chromatography afforded the analytically pure product (61.7 mg, 79% yield) as a yellow
solid. 1H NMR (CDCl3): δ = 2.36 (s, 6H), 2.65 (s, 6H), 3.34 (s, 6H), 6.88 (s, 2H), 7.69 (d, J = 8.5 Hz, 2H),
8.03 (d, J = 8.5 Hz, 2H). 13C NMR (CDCl3): δ = 20.01, 26.65, 29.68, 109.66, 127.14, 127.63, 134.28,
136.52, 198.40. HRMS (EI): m/z calcd for C18H21BN2O [M+]: 292.1747; found: 292.1724.
4-(1,3,5,6-Tetramethyl-1,3-dihydro-2H-benzo[d][1,3,2]diazaborol-2-yl)benzaldehyde (3g). Following
the general procedure B, 2g (56.1 mg, 0.242 mmol) was allowed to react with 1 for 1 h at 80 °C. Silica gel
1
chromatography afforded the analytically pure product (56.5 mg, 84% yield) as a yellow solid. H NMR
(CDCl3): δ = 2.36 (s, 6H), 3.33 (s, 6H), 6.88 (s, 2H), 7.76 (d, J=7.7 Hz 2H), 7.95 (d, J=6.8 Hz 2H), 10.08 (s,
1H). 13C NMR (CDCl3): δ = 6.34, 20.01, 29.68, 109.66, 124.60, 127.14, 134.28, 136.32, 192.61. HRMS
(EI): m/z calcd for C17H19BN2O [M+]: 278.1590; found: 278.1578.
3-(1,3,5,6-Tetramethyl-1,3-dihydro-2H-benzo[d][1,3,2]diazaborol-2-yl)benzonitrile (3h). Following the
general procedure B, the title compound was prepared starting from 2h (57.3 mg, 0.250 mmol). Silica gel
1
chromatography afforded the analytically pure product (49.6 mg, 72% yield) as a yellow solid. H NMR
(CDCl3): δ = 2.36 (s, 6H), 3.33 (s, 6H), 6.85 (s, 2H), 7.56 (t, J = 7.8 Hz, 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.80
(d, J = 7.5 Hz, 1H), 7.86 (s, 1H). 13C NMR (CDCl3): δ = 19.98, 29.69, 109.84, 112.18, 119.16, 127.22,
128.55, 131.92, 136.12, 137.32, 138.08. HRMS (EI): m/z calcd for C17H18BN3 [M+]: 275.1594; found:
275.1623.
1,3,5,6-Tetramethyl-2-(4-(trifluoromethyl)phenyl)-2,3-dihydro-1H-benzo[d][1,3,2]diazaborole
(3i).
Following the general procedure B, the title compound was prepared starting from 2i (66.9 mg, 0.246
mmol). Silica gel chromatography afforded the analytically pure product (64.9 mg, 83% yield) as a white
1
solid. H NMR (CDCl3): δ = 2.36 (s, 6H), 3.33 (s, 6H), 6.88 (s, 2H), 7.69 (s, 4H). 13C NMR (CDCl3): δ =
19.99, 29.68, 109.79, 124.34 (q, J = 270.78 Hz), 124.49 (q, J = 3.81 Hz), 127.08, 130.44 (q, J = 32.42 Hz),
134.21, 136.31. HRMS (EI): m/z calcd for C17H18BF3N2 [M+]: 317.1437; found: 317.1431.
1,3,5,6-Tetramethyl-2-(4-nitrophenyl)-2,3-dihydro-1H-benzo[d][1,3,2]diazaborole (3j). Following the
– S3 –